Just In
- 15 hrs ago Heeramandi Screening: Alia Bhatt, Ananya Panday, Rashmika Mandanna And Others Serve Finest Ethnic Style!
- 15 hrs ago From Alia Bhatt To Kriti Sanon, Korean Beauty Products That Bollywood Divas Swear By
- 18 hrs ago Exclusive: On World Malaria Day 2024, Dr Shares Danger Signs Parents Must Watch Out For In Child With Malaria
- 19 hrs ago Exclusive: Expert Debunks 5 Common Misconceptions About Expectant Mothers That You Need To Steer Clear From
Don't Miss
- Movies Pavi Caretaker Box Office Collection Day 1 Prediction: Dileep's Movie Expected To Open Strongly
- Sports Who Won Yesterday's IPL Match 41? SRH vs RCB, IPL 2024 on April 25: Royal Challengers Bangalore End Losing Streak
- Finance Bajaj Group Stock Declares Rs. 60/Share Dividend: Buy Ahead of Record Date On 28 June?
- News MEA Dismisses US Human Rights Report On Manipur As 'Biased And Misinformed'
- Automobiles Royal Enfield Unveils Revolutionary Rentals & Tours Service: Check Out All Details Here
- Technology Elon Musk’s X Is Launching a TV App Similar to YouTube for Watching Videos
- Education AICTE introduces career portal for 3 million students, offering fully-sponsored trip to Silicon Valley
- Travel Escape to Kalimpong, Gangtok, and Darjeeling with IRCTC's Tour Package; Check Itinerary
How Low Blood Flow Promotes Vascular Disease ?
{image- www.boldsky.com} In a rodent study on circulation, researchers have found evidence that a key protein, called cyclophilin A, leads to clogging of arteries in two ways, and that lowering levels of it opens them up.
The findings indicate that cyclophilin A can act as an exciting target in the design of drugs against atherosclerosis, the number one cause of heart attacks and strokes, which occur when vessels become completely blocked.
The current study unites three major discoveries in cardiovascular science in the last 20 years by providing strong evidence that cyclophilin A, a protein involved in the immune response, has dual roles in vascular disease.
Cyclophilin A recruits immune cells that cause inflammation, and it drives pathogenic growth and remodeling, when triggered by reactive oxygen species in diseased blood vessels.
"For years researchers worldwide have sought to determine exactly how low blood flow and the immune reaction to cholesterol deposits, along with the reactive oxygen species created by both, drive the progression of atherosclerosis. We are tremendously excited by these results because they provide solid evidence that cyclophilin A is at the center of it all," said Bradford C. Berk, M.D., Ph.D., professor of Medicine in the Aab Cardiovascular Research Institute within the University of Rochester Medical Center, and senior author of the study.
In the study, Berk's team genetically engineered one group of mice to produce less CyPA, another group to make more, and compared both groups to "normal" mice as all three groups experienced reduced blood flow in the carotid artery.
Reduced blood flow increased CyPA expression in the vascular wall, and promoted the migration of smooth muscle cells into the intima, where they began to grow (proliferate) and contribute to the formation of atherosclerotic lesions. Reduced flow, and the related increase in CyPA signaling, also caused the accumulation of inflammatory cells, an important component in the disease-related thickening of vessel walls. The effects were pronounced in the mice with extra capacity for CyPA production, and lessened in those with less CyPA.
The study, showed for the first time that in a live animal that cyclophilin A (CyPA) is secreted specifically by smooth muscle cells in response to the production of reactive oxygen species with several consequences.
First, CyPA signals for the production of pro-inflammatory molecules like E-selectin and vascular cell adhesion molecule 1 (VCAM-1), both of which call in immune cells circulating in the blood to the site of a cholesterol deposit in blood vessel wall and enable them to stick to it. This represents a first step in the inflammatory component of plaque formation.
The researchers also showed that CyPA stimulates important pathways (e.g. the ERK1/2 and JAK/STAT) that drive smooth muscle cells to divide and grow.
Also, CyPA may activate matrix metalloproteinases, enzymes that break down the barrier that usually keeps smooth muscle cells out of the intima, the site of their disease-related proliferation.
The study results are published in the latest edition of the journal Circulation.
- disorders cureA Revolutionary Capsule For Diabetes
- disorders cureCancer-Inhibiting Compound Found Under The Sea
- wellnessEating Broccoli May Reverse Diabetes Damage
- wellness7 Natural Cures For Atherosclerosis
- wellnessBrush Your Teeth To Cut Heart Disease Risk
- disorders cureVitamin B Deficiency Is Harmful II
- disorders cureGene Test That Can Help Prevent Heart Disease
- wellness40 Best Superfoods To Maintain Oral Health
- disorders curePlaques In The Brain May Cause Alzheimer's Disease, Study Reveals
- disorders curePeriodontitis: Symptoms, Causes, Risk factors, Treatment And Prevention
- wellnessTips On How To Get Rid Of Plaque In The Arteries And Veins Naturally
- wellnessOne Natural Remedy To Remove Tartar Buildup On Teeth Without Puncturing Your Pockets